Biohaven (BHVN) Capital Expenditures (2021 - 2026)

Biohaven has reported Capital Expenditures for 5 years, with the latest figure at $8000.0 in Q4 2025.

• Quarterly Capital Expenditures fell 83.67% year-over-year to $8000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $254000.0 (down 93.76% YoY) and the FY2025 annual result came in at $715000.0, down 82.34% from the prior year.
• Capital Expenditures eased to $8000.0 in Q4 2025 per BHVN's latest filing, from $13000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $4.5 million in Q3 2022 and troughed at $8000.0 in Q4 2025.
• A 5-year average of $863823.5 and a median of $470000.0 in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2024 and 2025: Capital Expenditures surged 395.63% in 2024, then plunged 97.87% in 2025.
• Over 5 years, Capital Expenditures stood at $799000.0 in 2021, then sank by 62.45% to $300000.0 in 2022, then jumped by 56.67% to $470000.0 in 2023, then plunged by 89.57% to $49000.0 in 2024, then sank by 83.67% to $8000.0 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered $8000.0, $13000.0, and $233000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.